Multi-Modal Biomarkers for Connecting the Dots in Clinical Development
- Leveraging multiple biomarker modalities for testing of the therapeutic hypothesis in clinical trials
- Machine Learning/ Artificial Intelligence tools for analysis of tissue fibrosis
- Exploring novel surrogate endpoints for drug registration in neglected tropical diseases